Thompson Siegel & Walmsley LLC Sells 31,610 Shares of Aeluma, Inc. $ALMU

Thompson Siegel & Walmsley LLC lowered its stake in shares of Aeluma, Inc. (NASDAQ:ALMU) by 21.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 118,390 shares of the company’s stock after selling 31,610 shares during the period. Thompson Siegel & Walmsley LLC owned 0.66% of Aeluma worth $2,033,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Quantbot Technologies LP bought a new stake in shares of Aeluma during the third quarter valued at approximately $29,000. BNP Paribas Financial Markets raised its position in shares of Aeluma by 79.2% during the third quarter. BNP Paribas Financial Markets now owns 1,934 shares of the company’s stock valued at $31,000 after buying an additional 855 shares during the last quarter. Osaic Holdings Inc. bought a new stake in shares of Aeluma during the second quarter valued at approximately $32,000. FNY Investment Advisers LLC raised its position in shares of Aeluma by 242.9% during the third quarter. FNY Investment Advisers LLC now owns 2,935 shares of the company’s stock valued at $47,000 after buying an additional 2,079 shares during the last quarter. Finally, Focus Partners Wealth bought a new stake in shares of Aeluma during the third quarter valued at approximately $73,000.

Insiders Place Their Bets

In related news, Director Steven Denbaars sold 12,500 shares of the firm’s stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $19.99, for a total value of $249,875.00. Following the completion of the transaction, the director directly owned 382,709 shares of the company’s stock, valued at approximately $7,650,352.91. This trade represents a 3.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jonathan Klamkin sold 20,000 shares of the firm’s stock in a transaction on Friday, May 1st. The shares were sold at an average price of $24.96, for a total transaction of $499,200.00. Following the completion of the transaction, the chief executive officer directly owned 2,403 shares of the company’s stock, valued at approximately $59,978.88. This trade represents a 89.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 52,500 shares of company stock valued at $1,011,075. 14.70% of the stock is currently owned by insiders.

Aeluma Stock Performance

ALMU stock opened at $26.56 on Wednesday. The firm has a fifty day moving average price of $18.92 and a 200 day moving average price of $17.25. Aeluma, Inc. has a fifty-two week low of $10.20 and a fifty-two week high of $31.79. The firm has a market cap of $486.31 million, a PE ratio of -75.88 and a beta of 3.94.

Aeluma (NASDAQ:ALMU) last posted its earnings results on Wednesday, May 13th. The company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.01. Aeluma had a negative net margin of 115.57% and a negative return on equity of 12.03%. The firm had revenue of $1.22 million during the quarter, compared to analyst estimates of $1.37 million.

Analysts Set New Price Targets

Several research firms have recently issued reports on ALMU. Wall Street Zen cut shares of Aeluma from a “sell” rating to a “strong sell” rating in a research report on Saturday, May 16th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aeluma in a research report on Monday, April 20th. Williams Trading set a $25.00 price objective on shares of Aeluma in a research report on Tuesday, March 3rd. Freedom Capital upgraded shares of Aeluma to a “strong-buy” rating in a research report on Tuesday, March 31st. Finally, UBS Group reiterated a “buy” rating on shares of Aeluma in a research report on Tuesday, March 3rd. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $25.33.

Aeluma Company Profile

Aeluma, Inc develops optoelectronic and electronic devices in the United States. The company manufactures semiconductor materials and chips using compound semiconductors on diameter substrates that are used to manufacture mass market microelectronics. It offers its devices for use in mobile, automotive, AI, defence and aerospace, communication, AR/VR, and HPC applications, as well as laser emitters, transistors for integrated circuits, quantum photonic circuits, and solar cells applications. Aeluma, Inc was formerly known as Parc Investments, Inc and changed its name to Aeluma, Inc June 2021.